Beschreibung
Mucosal cytokine profiles in ulcerative colitis patients treated with curcumin reveal reductions in pro-inflammatory mediators including TNF-alpha and IL-6. Anti-inflammatory cytokines showed modest increases.
Figure 22
ChartSource Paper
The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.Cite This Figure
![Figure 22: Mucosal cytokine profiles in ulcerative colitis patients treated with curcumin reveal reductions in pro-inflammatory mediators including TNF-alpha and IL-6. Anti-inflammatory cytokines showed modest increases.]() > Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)
<figure> <img src="" alt="Mucosal cytokine profiles in ulcerative colitis patients treated with curcumin reveal reductions in pro-inflammatory mediators including TNF-alpha and IL-6. Anti-inflammatory cytokines showed modest increases." /> <figcaption>Figure 22. Mucosal cytokine profiles in ulcerative colitis patients treated with curcumin reveal reductions in pro-inflammatory mediators including TNF-alpha and IL-6. Anti-inflammatory cytokines showed modest increases.<br> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption> </figure>